Autophagy gene-dependent intracellular immunity triggered by interferon-γ.
Autorzy:
McAllaster MR; Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA.; Vir Biotechnology , San Francisco, California, USA. Bhushan J; Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA. Balce DR; Vir Biotechnology , San Francisco, California, USA.; Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri, USA. Orvedahl A; Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri, USA.; Department of Pediatrics, Washington University School of Medicine , St. Louis, Missouri, USA. Park A; Vir Biotechnology , San Francisco, California, USA.; Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri, USA. Hwang S; Vir Biotechnology , San Francisco, California, USA. Sullender ME; Division of Infectious Diseases, Department of Medicine, Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine , St. Louis, Missouri, USA. Sibley LD; Department of Molecular Microbiology, Washington University School of Medicine , St. Louis, Missouri, USA. VirginHW; Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri, USA.; Department of Internal Medicine, UT Southwestern Medical Center , Dallas, Texas, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2023 Oct 31, pp. e0233223. Date of Electronic Publication: 2023 Oct 31.
Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Autorzy:
Momont C; Vir Biotechnology, San Francisco, CA, USA. Dang HV; Vir Biotechnology, San Francisco, CA, USA. Zatta F; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Hauser K; Vir Biotechnology, San Francisco, CA, USA. Wang C; Vir Biotechnology, St. Louis, MO, USA. di Iulio J; Vir Biotechnology, San Francisco, CA, USA. Minola A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA. De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Branch K; Vir Biotechnology, San Francisco, CA, USA. Donermeyer D; Vir Biotechnology, St. Louis, MO, USA. Vyas S; Vir Biotechnology, San Francisco, CA, USA. Chen A; Vir Biotechnology, San Francisco, CA, USA. Ferri E; Vir Biotechnology, San Francisco, CA, USA. Guarino B; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Powell AE; Vir Biotechnology, San Francisco, CA, USA. Spreafico R; Vir Biotechnology, San Francisco, CA, USA. Yim SS; Vir Biotechnology, San Francisco, CA, USA. Balce DR; Vir Biotechnology, San Francisco, CA, USA. Bartha I; Vir Biotechnology, San Francisco, CA, USA. Meury M; Vir Biotechnology, San Francisco, CA, USA. Croll TI; Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge, UK. Belnap DM; School of Biological Sciences, Department of Biochemistry, University of Utah, Salt Lake City, UT, USA. Schmid MA; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Schaiff WT; Vir Biotechnology, St. Louis, MO, USA. Miller JL; Vir Biotechnology, San Francisco, CA, USA. Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Telenti A; Vir Biotechnology, San Francisco, CA, USA. VirginHW; Vir Biotechnology, San Francisco, CA, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA. Rosen LE; Vir Biotechnology, San Francisco, CA, USA. Purcell LA; Vir Biotechnology, San Francisco, CA, USA. Lanzavecchia A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Snell G; Vir Biotechnology, San Francisco, CA, USA. . Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. . Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Jul; Vol. 619 (7970), pp. E50.
A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Autorzy:
Momont C; Vir Biotechnology, San Francisco, CA, USA. Dang HV; Vir Biotechnology, San Francisco, CA, USA. Zatta F; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Hauser K; Vir Biotechnology, San Francisco, CA, USA. Wang C; Vir Biotechnology, St. Louis, MO, USA. di Iulio J; Vir Biotechnology, San Francisco, CA, USA. Minola A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA. De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Branch K; Vir Biotechnology, San Francisco, CA, USA. Donermeyer D; Vir Biotechnology, St. Louis, MO, USA. Vyas S; Vir Biotechnology, San Francisco, CA, USA. Chen A; Vir Biotechnology, San Francisco, CA, USA. Ferri E; Vir Biotechnology, San Francisco, CA, USA. Guarino B; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Powell AE; Vir Biotechnology, San Francisco, CA, USA. Spreafico R; Vir Biotechnology, San Francisco, CA, USA. Yim SS; Vir Biotechnology, San Francisco, CA, USA. Balce DR; Vir Biotechnology, San Francisco, CA, USA. Bartha I; Vir Biotechnology, San Francisco, CA, USA. Meury M; Vir Biotechnology, San Francisco, CA, USA. Croll TI; Cambridge Institute for Medical Research, Department of Haematology, University of Cambridge, Cambridge, UK. Belnap DM; School of Biological Sciences, Department of Biochemistry, University of Utah, Salt Lake City, UT, USA. Schmid MA; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Schaiff WT; Vir Biotechnology, St. Louis, MO, USA. Miller JL; Vir Biotechnology, San Francisco, CA, USA. Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Telenti A; Vir Biotechnology, San Francisco, CA, USA. VirginHW; Vir Biotechnology, San Francisco, CA, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA. Rosen LE; Vir Biotechnology, San Francisco, CA, USA. Purcell LA; Vir Biotechnology, San Francisco, CA, USA. Lanzavecchia A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Snell G; Vir Biotechnology, San Francisco, CA, USA. . Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. . Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. .
Pokaż więcej
Źródło:
Nature [Nature] 2023 Jun; Vol. 618 (7965), pp. 590-597. Date of Electronic Publication: 2023 May 31.
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.
Autorzy:
Marzi R; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Bassi J; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Silacci-Fregni C; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Bartha I; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Muoio F; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Culap K; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Sprugasci N; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Lombardo G; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Saliba C; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Cameroni E; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Cassotta A; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland. Low JS; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.; Institute of Microbiology, ETH Zurich, Zurich, Switzerland. Walls AC; Department of Biochemistry, University of Washington, Seattle, WA, USA. McCallum M; Department of Biochemistry, University of Washington, Seattle, WA, USA. Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA, USA. Bowen JE; Department of Biochemistry, University of Washington, Seattle, WA, USA. Dellota EA Jr; Vir Biotechnology, San Francisco, CA, USA. Dillen JR; Vir Biotechnology, San Francisco, CA, USA. Czudnochowski N; Vir Biotechnology, San Francisco, CA, USA. Pertusini L; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland. Terrot T; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland. Lepori V; Independent Physician, Bellinzona, Switzerland. Tarkowski M; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milan, Italy. Riva A; Department of Biomedical and Clinical Sciences 'L. Sacco', University of Milan, Milan, Italy.; III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy. Biggiogero M; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland. Franzetti-Pellanda A; Clinical Research Unit, Clinica Luganese Moncucco, Lugano, Switzerland. Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland. Ferrari P; Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Clinical School, University of New South Wales, Sydney, NSW, Australia. Ceschi A; Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland. Giannini O; Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland.; Department of Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. Havenar-Daughton C; Vir Biotechnology, San Francisco, CA, USA. Telenti A; Vir Biotechnology, San Francisco, CA, USA. Arvin A; Vir Biotechnology, San Francisco, CA, USA. VirginHW; Vir Biotechnology, San Francisco, CA, USA.; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA. Sallusto F; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.; Institute of Microbiology, ETH Zurich, Zurich, Switzerland. Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA. Lanzavecchia A; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Corti D; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. Piccoli L; Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Pokaż więcej
Źródło:
IScience [iScience] 2023 Jan 20; Vol. 26 (1), pp. 105726. Date of Electronic Publication: 2022 Dec 05.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies